JPMorgan (NYSE: AMJB) prices MerQube Vol Advantage review notes
JPMorgan Chase Financial Company LLC is offering $795,000 of structured Review Notes linked to the MerQube US Large-Cap Vol Advantage Index, fully and unconditionally guaranteed by JPMorgan Chase & Co. The notes have a price to public of $1,000 per note, including $50 of fees and commissions, for issuer proceeds of $950 per note, and an estimated value at pricing of $886.60 per $1,000 note. They may be automatically called as early as December 16, 2026 if the Index is at or above the applicable Call Value, paying back principal plus a Call Premium Amount based on a 13.95% Call Premium Rate. If the notes are never called and the Final Value of the Index is below the 60% Barrier Amount on the final Review Date, repayment at maturity will be $1,000 plus $1,000 times the Index Return, so investors can lose more than 40% and up to all principal. The Index includes a 6.0% per annum daily deduction, which creates a persistent drag on performance, and the notes pay no interest and provide no dividends. They are unsecured, unsubordinated obligations subject to the credit risk of both JPMorgan Financial and JPMorgan Chase & Co., and will not be listed on any securities exchange.
Positive
- None.
Negative
- None.
FAQ
What is JPMorgan AMJB offering in this MerQube US Large-Cap Vol Advantage note deal?
JPMorgan Chase Financial Company LLC is issuing $795,000 of structured Review Notes linked to the MerQube US Large-Cap Vol Advantage Index, fully and unconditionally guaranteed by JPMorgan Chase & Co. The notes are unsecured, unsubordinated obligations and are sold in minimum denominations of $1,000 and integral multiples thereof.
How do the automatic call and potential returns work on the JPMorgan AMJB MerQube Review Notes?
On each Review Date from December 16, 2026 through December 16, 2030, if the Index closing level is at or above the applicable Call Value, the notes are automatically called. Investors then receive $1,000 plus a Call Premium Amount per note, calculated as $1,000 × 13.95% × N / 252, where N increases with each Review Date. Example Call Premium Amounts are $140.0536 on the first Review Date and $695.8393 on the final Review Date.
What is the downside risk to principal on the JPMorgan AMJB MerQube-linked notes?
If the notes have not been automatically called and the Final Value of the Index on the final Review Date is below the Barrier Amount of 60% of the Initial Value, the payment at maturity is $1,000 + ($1,000 × Index Return). In this case, investors lose 1% of principal for every 1% the Final Value is below the Initial Value, meaning losses can exceed 40% and reach a total loss of principal.
What key features of the MerQube US Large-Cap Vol Advantage Index affect these JPMorgan AMJB notes?
The Index provides rules-based exposure to E-mini S&P 500 futures with a target implied volatility of 35% and exposure capped between 0% and 500%. It is subject to a 6.0% per annum daily deduction, which offsets gains, magnifies losses and causes the Index to lag an identical index without this deduction. The Index may also be significantly leveraged or significantly uninvested at times, affecting performance.
What is the pricing, estimated value and fee structure of the JPMorgan AMJB MerQube Review Notes?
Each note has a $1,000 price to public, including $50 of fees and commissions, resulting in $950 of proceeds to the issuer per note. The total transaction size is $795,000, with total fees and commissions of $39,750 and issuer proceeds of $755,250. The estimated value at pricing is $886.60 per $1,000 note, reflecting internal funding rates, hedging costs and dealer compensation.
What are the main risks highlighted for investors in JPMorgan AMJB MerQube Review Notes?
Key risks include no principal protection, potential loss of more than 40% and up to all principal if the Final Value is below the Barrier Amount, no interest or dividends, and a 6.0% per annum daily deduction on the Index that can steadily erode performance. The notes are also subject to the credit risk of JPMorgan Financial and JPMorgan Chase & Co., may be illiquid because they are not exchange-listed, and may trade below the original issue price in the secondary market.
When do the JPMorgan AMJB MerQube Review Notes mature and what are key dates?
The notes priced on December 15, 2025 and are expected to settle on or about December 18, 2025. Review Dates run from December 16, 2026 to December 16, 2030, and the scheduled Maturity Date is December 19, 2030, which also serves as the Call Settlement Date if the notes are automatically called on the final Review Date.